IBBQ's concentrated biotech play has delivered a higher one-year return, while IXJ'S diversified global healthcare fund has been much less volatile.

Here's a look at some local developments that underscore the opportunities and challenges that lie ahead for Massachusetts.

The next one may be something many executives still treat as niche: biology made usable through digital systems. A profound ...

The former Rhode Island anesthesiologist who spent more than 20 years on the run to avoid being prosecuted on sexual assault ...

Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

Pakistan achieved another milestone in international science competitions as the national team secured a Silver Medal and a ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Billionaire Steve Cohen still backs biotech Evommune despite trial setbacks, highlighting its potential for treating chronic ...

Asharq Al Awsat The Saudi Biology Team won four international awards at the 37th International Biology Olympiad (IBO 2026), held in Vilnius, Lithuania, from July 12 to 19. The competition brought ...

Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has raised ...

A local company has sold a portion of its Dayton-made medical treatment portfolio to a multi-billion-dollar firm. The ...